Insulin resistance, blood sugar regulation, metabolic syndrome, and body composition
413 articoli
A 6-month AI-driven personalized diet intervention cut BMI by 33% and reduced biological age by 8 years in morbidly obese patients.
A sweeping review of GLP-1 agonists, tirzepatide, and emerging hormone combos reshaping obesity treatment in 2025.
The TRIUMPH program tests retatrutide across 5,800+ patients using a novel basket trial design to simultaneously tackle obesity and its complications.
Un'analisi approfondita a livello molecolare sulla cinetica di formazione degli AGE, sulle isoforme di RAGE, sulle reti trascrizionali a valle e sugli interventi basati sull'evidenza — per chi vuole il quadro meccanicistico completo.
Baxdrostat becomes the first-in-class aldosterone synthase inhibitor approved to treat resistant hypertension alongside existing drugs.
Vai oltre le basi ed esplora i meccanismi biochimici alla base della glicazione — dalla cascata della reazione di Maillard alla segnalazione RAGE e al cross-linking tissutale — per capire perché i AGE sono centrali nell'invecchiamento e nelle malattie metaboliche.
Scopri come le molecole di zucchero danneggiano silenziosamente le tue proteine e cellule nel tempo — e cosa puoi fare per rallentare questo subdolo processo di invecchiamento.
FDA approval of the first T1D delay drug nearly doubled islet autoantibody testing, but critical gaps remain in screening healthy children.
A new review links feline age-related obesity to SASP-driven chronic inflammation, offering translational insights for human metabolic disease.
The triple agonist retatrutide drives deep metabolic shifts beyond weight loss, improving key biomarkers of cardiovascular and insulin health.
Scientists identify IL-11 as a molecular brake on beige fat thermogenesis, and show blocking it improves metabolism in obese mice.
Diabetes drugs like empagliflozin show surprising anti-aging effects — mimicking caloric restriction and reducing senescent cell burden.
